atezolizumab/bevacizumab

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

March, 2025

atezolizumab/bevacizumab

Dec 15, 2024, 14:21 | Blog

Rasha Aboelhassan: How can we manage HCC patients with high-risk features?

Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, posted on LinkedIn: “How can we manage…

Jun 9, 2024, 10:17 | Insight

Arndt Vogel shares news from EASL 2O24

Arndt Vogel shared the following posts from EASL 2O24 on X: "Liver transplantation following HCC…

All: 2 Posts: 1 - 100

'

Meet the New AACR Board of Directores for 2025-2028 Term

'

Do Artificial Sweeteners Cause Cancer? Myths and Facts

'

King Charles III Hospitalized Following Side Effects from Cancer Treatment

'

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

'

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023